A detailed history of Umpqua Bank transactions in Amgen Inc stock. As of the latest transaction made, Umpqua Bank holds 1,997 shares of AMGN stock, worth $578,930. This represents 0.24% of its overall portfolio holdings.

Number of Shares
1,997
Previous 2,047 2.44%
Holding current value
$578,930
Previous $640 Million 0.6%
% of portfolio
0.24%
Previous 0.25%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 30, 2024

SELL
$309.38 - $337.38 $15,469 - $16,869
-50 Reduced 2.44%
1,997 $643 Million
Q2 2024

Aug 06, 2024

BUY
$262.75 - $319.31 $13,137 - $15,965
50 Added 2.5%
2,047 $640 Million
Q1 2024

May 13, 2024

BUY
$268.87 - $324.56 $536,933 - $648,146
1,997 New
1,997 $568 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $155B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Umpqua Bank Portfolio

Follow Umpqua Bank and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Umpqua Bank, based on Form 13F filings with the SEC.

News

Stay updated on Umpqua Bank with notifications on news.